UNIPHOS ENT 2023-24 Annual Report Analysis

Thu, 29 Aug

UNIPHOS ENT has announced its results for the year ended March 2024. Let us have a look at the detailed performance review of the company during FY23-24.

UNIPHOS ENT Income Statement Analysis

• Operating income during the year rose 3340.8% on a year-on-year (YoY) basis.
• The company's operating profit was by NA YoY during the fiscal. Operating profit margins witnessed a growth and down at 6.1% in FY24 as against 194.5% in FY23.
• Depreciation charges increased by 38.1% increased by 0.0% YoY, respectively.
• Other income declined by 0.5% YoY.
• Net profit for the year declined by 1.6% YoY.
• Net profit margins during the year declined from 2664.8% in FY23 to 76.2% in FY24.

UNIPHOS ENT Income Statement 2023-24

No. of Mths Year Ending		12 Mar-23*	12 Mar-24*	% Change
Net Sales	Rs m	15	506	3,340.8%
Other income	Rs m	431	429	-0.5%
Total Revenues	Rs m	446	935	109.9%
Gross profit	Rs m	-29	-31	NA
Depreciation	Rs m	6	8	38.1%
Interest	Rs m	0	0	0.0%
Profit before tax	Rs m	396	389	-1.7%
Tax	Rs m	4	3	-16.9%
Profit after tax	Rs m	392	386	-1.6%
Gross profit margin	%	-194.5	-6.1
Effective tax rate	%	1.0	0.8
Net profit margin	%	2,664.8	76.2

Must See: These Segments are Witnessing Incredible Growth with Modi's Push

UNIPHOS ENT Balance Sheet Analysis

• The company's current liabilities during FY24 stood at Rs 21 million as compared to Rs 11 million in FY23, thereby witnessing an increase of 94.3%.
• Current assets fell 10% and stood at Rs 480 million, while fixed assets fell 34% and stood at Rs 20 billion in FY24.
• Overall, the total assets and liabilities for FY24 stood at Rs 21 billion as against Rs 31 billion during FY23, thereby witnessing a fall of 34%.

UNIPHOS ENT Balance Sheet as on March 2024

No. of Mths Year Ending		12 Mar-23*	12 Mar-24*	% Change
Networth	Rs m	29,976	20,755	-30.8
Current Liabilities	Rs m	11	21	94.3
Long-term Debt	Rs m	0	0	0.0
Total Liabilities	Rs m	30,955	20,560	-33.6
Current assets	Rs m	532	480	-9.6
Fixed Assets	Rs m	30,423	20,080	-34.0
Total Assets	Rs m	30,955	20,560	-33.6

UNIPHOS ENT Cash Flow Statement Analysis

• UNIPHOS ENT's cash flow from operating activities (CFO) during FY24 stood at Rs -35 million, an improvement of 136.5% on a YoY basis.
• Cash flow from investing activities (CFI) during FY24 stood at Rs 502 million, an improvement of 23.5% on a YoY basis.
• Cash flow from financial activities (CFF) during FY24 stood at Rs -452 million on a YoY basis.
• Overall, net cash flows for the company during FY24 stood at Rs 15 million from the Rs -1 million net cash flows seen during FY23.

UNIPHOS ENT Cash Flow Statement 2023-24

Particulars	No. of months	12	12	% Change
	Year Ending	Mar-23	Mar-24
Cash Flow from Operating Activities	Rs m	-15	-35	-
Cash Flow from Investing Activities	Rs m	406	502	23.5%
Cash Flow from Financing Activities	Rs m	-393	-452	-
Net Cash Flow	Rs m	-1	15	-

Current Valuations for UNIPHOS ENT

• The trailing twelve-month earnings per share (EPS) of the company stands at Rs 5.6, an decline from the EPS of Rs 5.6 recorded last year.
• The price to earnings (P/E) ratio, at the current price of Rs 170.2, stands at 30.7 times its trailing twelve months earnings.
• The price to book value (P/BV) ratio at current price levels stands at 0.6 times, while the price to sales ratio stands at 23.4 times.
• The company's price to cash flow (P/CF) ratio stood at 27.4 times its end-of-year operating cash flow earnings.

Per Share Data/Valuations

No. of Mths Year Ending		12 Mar-23*	12 Mar-24*
Sales per share (Unadj.)	Rs	0.2	7.3
TTM Earnings per share	Rs	5.6	5.6
Diluted earnings per share	Rs	5.6	5.6
Price to Cash Flow	x	26.9	27.4
TTM P/E ratio	x	27.3	30.7
Price / Book Value ratio	x	0.3	0.5
Market Cap	Rs m	10,121	10,806
Dividends per share (Unadj.)	Rs	6.5	5.7

Ratio Analysis for UNIPHOS ENT

• Solvency Ratios

Current Ratio: The company's current ratio deteriorated and stood at 23.4x during FY24, from 50.4x during FY23. The current ratio measures the company's ability to pay short-term and long-term obligations.

• Profitability Ratios

Return on Equity (ROE): The ROE for the company improved and stood at 1.9% during FY24, from 1.3% during FY24. The ROE measures the ability of a firm to generate profits from its shareholders capital in the company.

Return on Capital Employed (ROCE): The ROCE for the company improved and stood at 1.9% during FY24, from 1.3% during FY23. The ROCE measures the ability of a firm to generate profits from its total capital (shareholder capital plus debt capital) employed in the company.

Return on Assets (ROA): The ROA of the company improved and stood at 1.9% during FY24, from 1.3% during FY23. The ROA measures how efficiently the company uses its assets to generate earnings.

Key Ratio Analysis

No. of Mths Year Ending		12 Mar-23*	12 Mar-24*
Current ratio	x	50.4	23.4
Debtors’ Days	Days	0	35
Interest coverage	x	0.0	0.0
Debt to equity ratio	x	0.0	0.0
Return on assets	%	1.3	1.9
Return on equity	%	1.3	1.9
Return on capital employed	%	1.3	1.9

To see how UNIPHOS ENT has performed over the last 5 years, please visit here.

UNIPHOS ENT Share Price Performance

Over the last one year, UNIPHOS ENT share price has moved down from Rs 160.9 to Rs 0.0, registering a loss of Rs 160.9 or around 100.0%.

Overall, the NIFTY 50 is down 0.1% over the year.

(To know more, check out historical annual results for UNIPHOS ENT and quarterly results for UNIPHOS ENT)